The Cost of Slow Data: Why Timing Saves Lives

The Cost of Slow Data: Why Timely Health Information Saves Lives

by Victory Odesanmi

A patient sits down. The physician has maybe 20 minutes, and the first 10 usually go to finding out why the patient is there, a history the patient has often already given, on an intake form, to a referring provider, or at an earlier visit. That's not a scheduling problem. It's a data problem: the information existed before the appointment started. It just didn't reach the room.

Healthcare generates an enormous amount of patient data, but most of it doesn't move with the patient. It sits in systems that don't talk to each other, or in notes nobody had time to read before the door opened. And in several well-studied conditions, how quickly the right information reaches a clinician doesn't just shape the visit. It shapes survival.

What the research actually shows

In sepsis, every additional hour between a patient's arrival and their first dose of antibiotics is associated with a 10% increase in the odds of dying within a year, across a study of nearly 11,000 patients (Peltan et al., CHEST, 2019).

In stroke, patients treated within 60 minutes of arriving at hospital have meaningfully better one-year survival than those treated after: 32.1% mortality versus 35.8%, in a study of more than 61,000 patients (Man et al., JAMA, 2020).

In cancer care, a systematic review spanning 1.2 million patients across seven cancer types found that a one-month delay in starting treatment raised the risk of death by 6 to 13%, with the risk compounding the longer treatment was pushed back (Hanna et al., The BMJ, 2020).

Three different diseases, three different points in a patient's care, and the same underlying pattern: time lost between recognizing a problem and acting on it tends to cost something. That's the evidence behind the idea that timely health information saves lives. It's a conclusion drawn from these clinical studies, not from any single product or tool.

Where the delay actually starts

Much of that delay starts earlier and more quietly than a slow test result. A landmark 1992 study found that a patient's history alone accounted for the correct diagnosis in roughly three-quarters of cases, with physical exams and lab work mostly confirming a direction the history had already pointed to (Peterson et al., Western Journal of Medicine, 1992). The conversation itself carries most of the diagnostic weight.

Yet that conversation is usually compressed into a short intake form, or whatever the patient can recall under time pressure in the exam room, frequently the same details they've already given somewhere else. The bottleneck isn't a lack of information. It's that the information the patient already has doesn't reach the physician before they walk in.

What Athel does about it

This is where Athel, your AI Co-Clinician, fits in. Athel puts together a structured timeline of a patient's current symptoms alongside relevant medical, surgical, and medication history before the appointment starts, and flags details worth a second look (a family history of early cardiac disease, a supplement that might interact with a medication) for the physician to review. It doesn't diagnose anything, and it doesn't make the call. What it does is make sure more of the patient's story is already on the table when the physician walks in, so the time in the room goes toward clinical thinking instead of information recovery.

None of the outcomes above happened because a system diagnosed, treated, or triaged a patient on its own. They happened because a clinician acted on information sooner. The physician is still the one interpreting findings, weighing possibilities, and making the call. What changes is how much runway they have to do that well. Given what the research shows about the cost of a delay, that's a meaningful place to start.

See how Athel's pre-visit interview gets a fuller patient history to physicians before the appointment begins.

"Physician reviewing a structured patient timeline on a tablet before walking into an exam room."

Sources (accessed 2026-09-22)

1. Peltan ID, et al. ED Door-to-Antibiotic Time and Long-term Mortality in Sepsis. CHEST, 2019. https://journal.chestnet.org/article/S0012-3692(19)30157-6/abstract

2. Man S, Xian Y, Holmes DN, et al. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke. JAMA, 2020. https://jamanetwork.com/journals/jama/fullarticle/2766633

3. Hanna TP, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. The BMJ, 2020. https://www.bmj.com/content/371/bmj.m4087

4. Peterson MC, Holbrook JH, Von Hales D, Smith NL, Staker LV. Contributions of the history, physical examination, and laboratory investigation in making medical diagnoses. Western Journal of Medicine, 1992. https://pubmed.ncbi.nlm.nih.gov/1536065/